An in-depth investigation of NAs-induced osteoporosis adverse events: a real-world, network toxicology and molecular docking analysis
This study comprehensively reported the risk and mechanisms of osteoporosis caused by the clinical use of NAs drugs, and provided more detailed recommendations for clinical improvement and prevention of adverse events.
Authors
- Jingkai Di (ORCID: https://orcid.org/0000-0002-2814-9400)
- Chuan Xiang (ORCID: https://orcid.org/0000-0002-1121-6443)
- Shuang Wang (ORCID: https://orcid.org/0000-0002-8261-0018)
- Qin Yao (ORCID: https://orcid.org/0000-0003-4485-4545)
- Zijian Guo (ORCID: https://orcid.org/0000-0002-2263-6152)
- Lujia Liu (ORCID: https://orcid.org/0000-0001-6744-5459)
- Likun Qi
Institutions
- Shanxi Medical University (CN)
- Taiyuan Heavy Industry (China) (CN)
- Second Hospital of Shanxi Medical University (CN)
- Shanxi Academy of Medical Sciences (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-07-04
- DOI
- https://doi.org/10.3389/fmed.2025.1605024
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00